Clinical Trial Update: Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency [Phase 1, Phase 2]

View source ↗

Summary

Update on the FE203799 metabolic balance study in patients with short bowel syndrome and intestinal insufficiency. The Phase 1 and Phase 2 trials have completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• FE203799

Snippet

Sponsor: GlyPharma Therapeutics | Conditions: SBS - Short Bowel Syndrome | Phase 1, Phase 2 | Status: COMPLETED